Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymer Micelles + Gemcitabine + Lenvatinib/Anlotinib in Advanced Sarcomas
NCT07359053Phase 2Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Dec 2025
- Primary completion
- Sep 2027
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel polymer micelles for injection + cisplatin + sintilimab in bone sarcoma, soft tissue sarcoma (STS), sponsored by Shanghai Sixth People's Hospital. Started Dec 2025; status: recruiting.
02
Drugs
paclitaxel polymer micelles for injection + cisplatin + sintilimab
03
Conditions
bone sarcomasoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07359053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07359053.